BIM
MYGN icon

BlackRock Investment Management’s Myriad Genetics MYGN Stock Holding History

BlackRock Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.22M Sell
253,090
-588
-0.2% -$10.6K ﹤0.01% 1705
2016
Q3 		$5.22M Sell
253,678
-428
-0.2% -$10.9K 0.01% 1453
2016
Q2 		$7.78M Buy
254,106
+14,591
+6% +$507K 0.01% 1114
2016
Q1 		$8.96M Buy
239,515
+7,081
+3% +$267K 0.01% 992
2015
Q4 		$10M Buy
232,434
+1,354
+0.6% +$57.2K 0.01% 940
2015
Q3 		$8.66M Sell
231,080
-2,890
-1% -$103K 0.01% 1012
2015
Q2 		$7.95M Buy
233,970
+208,854
+832% +$7.1M 0.01% 1156
2015
Q1 		$889K Sell
25,116
-1,253
-5% -$44.8K ﹤0.01% 2602
2014
Q4 		$898K Sell
26,369
-637
-2% -$22.6K ﹤0.01% 2614
2014
Q3 		$1.04M Sell
27,006
-24,703
-48% -$922K ﹤0.01% 2495
2014
Q2 		$2.01M Sell
51,709
-151,440
-75% -$5.63M ﹤0.01% 2071
2014
Q1 		$6.95M Buy
203,149
+8,574
+4% +$266K 0.01% 1147
2013
Q4 		$4.08M Buy
194,575
+133,834
+220% +$3.38M 0.01% 1499
2013
Q3 		$1.43M Buy
60,741
+7,607
+14% +$216K ﹤0.01% 2187
2013
Q2 		$1.43M Buy
+53,134
New +$1.54M ﹤0.01% 2113

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Investment Management's MYGN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Myriad Genetics (MYGN) stake by 0.23% in Q4 2016, selling an estimated $10.6K and leaving 253,090 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

BlackRock Investment Management first reported a position in MYGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $10M in Q4 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q4 2016.

  • BlackRock Investment Management held 253,090 shares of Myriad Genetics worth $4.22M as of Q4 2016.
  • BlackRock Investment Management sold 588 Myriad Genetics shares in Q4 2016, an estimated $10.6K.
  • Myriad Genetics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1705 holding.
  • BlackRock Investment Management first reported a position in Myriad Genetics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Myriad Genetics position peaked at $10M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.